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Pore-forming toxins (PFTs) are proteins that are
secreted as soluble molecules and are inserted into
membranes to form oligomeric transmembrane
pores. In this paper, we report the crystal structure
of Fragaceatoxin C (FraC), a PFT isolated from the
sea anemone Actinia fragacea, at 1.8 A˚ resolution.
It consists of a crown-shaped nonamer with an
external diameter of about 11.0 nm and an internal
diameter of approximately 5.0 nm. Cryoelectron
microscopy studies of FraC in lipid bilayers reveal
the pore structure that traverses the membrane.
The shape and dimensions of the crystallographic
oligomer are fully consistent with the membrane
pore. The FraC structure provides insight into the
interactions governing the assembly process and
suggests the structural changes that allow for
membrane insertion. We propose a nonameric pore
model that spans the membrane by forming a lipid-
free a-helical bundle pore.
INTRODUCTION
The integrity of the plasma membrane is crucial for the appro-
priate functionandstability of living cells.Manypathogens induce
injury to target cells through the action of diverse toxic proteins
that create membrane pores. These nonselective holes breach
thecellwall, producingan ion imbalanceor uncontrolled ionefflux
and permeabilization to a variety of molecules depending on the
pore size (Iacovache et al., 2008; Tweten, 2005). Thus, the action
of these pore-formingmolecules disturbs themembrane integrity
and can lead to cell death (Bischofberger et al., 2009).
Pore-forming toxins (PFTs) are produced by a wide range of
organisms, such as bacteria, insects, marine invertebrates,Structure 19, 18poisonous reptiles, and mammals, for different purposes,
including defense, attack, or signaling (Parker and Feil, 2005).
In humans, it has been postulated that fibrillar amyloid deposits
that result from neurodegenerative diseases can form ring-
shaped structures that are very similar to bacterial PFTs (Lashuel
and Lansbury, 2006), and it is known that Bcl2-like proteins
trigger apoptosis by creating pores in mitochondrial membranes
(Kroemer et al., 2007). Additionally, structural analysis has
revealed similarities between some bacterial PFTs and other
proteins that perform a range of functions (Anderluh and Lakey,
2008). Because of the above-mentioned properties for recog-
nizing and permeabilizing biological membranes, these pores
have potential medical applications in cancer therapeutics
(Abrami et al., 2008; Panchal et al., 2002; Potrich et al., 2005)
and biosensor technology (Astier et al., 2005).
PFTs are generally secreted as soluble monomers that diffuse
toward the membrane of a target cell. Upon membrane binding,
the monomers undergo a conformational change that exposes
an amphipathic surface, which drives membrane insertion. The
transition from the bound to inserted state usually takes place
through an oligomeric intermediate commonly known as the
prepore (Walker et al., 1992, 1995).
PFTs are usually classified according to the type of secondary
structure elements they use to cross the lipid bilayer upon pore
formation (Gouaux, 1997). Hence, these toxins are usually
divided into two categories: a-PFTs and b-PFTs. The atomic
structures of several PFTs in their water-soluble state are known
(Iacovache et al., 2010), while a few structures of the oligomeric
state have been solved. Prime examples include the crystal
structure of the Staphylococcus aureus a-hemolysin pore
(Song et al., 1996) and the structure of the water-soluble state
of its homolog, Panton-Valentine leukocidin (Olson et al.,
1999). These two structures provide insight into how b-PFTs
oligomerize to eventually form a pore. Another important
example is the structure of perfringolysin O in its water-soluble
state (Rossjohn et al., 1997) and models of both prepore and
pore forms based on EM data (Dang et al., 2005). In addition to
the heptameric a-hemolysin from S. aureus, the crystal structure1–191, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 181
Structure
X-ray and Cryo-EM Structures of Fragaceatoxin Cof the dodecameric a-PFT cytolysin A (ClyA) from Escherichia
coli has also been solved. ClyA is the only PFT for which the
structures of both the soluble state (Wallace et al., 2000) and
the assembled pore state (Mueller et al., 2009) have been
reported.
One of the representatives of the a-PFT group is a family of
eukaryotic toxins called actinoporins, or cytolysins (Alegre-Ce-
bollada et al., 2007; Kristan et al., 2009). Actinoporins are
extremely potent cytolytic toxins produced by sea anemones,
endowed with both predatory and defense functions (Alvarez
et al., 2009; Kristan et al., 2009). Equinatoxin-II (Eqt-II) from
Actinia equina and sticholysin-II (Stn-II) from Stichodactyla heli-
anthus are two members of this family whose three-dimensional
(3D) structures have been solved by X-ray crystallography (Atha-
nasiadis et al., 2001; Mancheno et al., 2003). They consist of
a b sandwich core flanked by two short a helices. The N-terminal
a helix is amphipathic and seems to be able to detach from the
main body of the molecule to participate in the formation of the
pore wall (Hong et al., 2002).
Crosslinking experiments (Belmonte et al., 1993), kinetic data
(Tejuca et al., 1996), and electron microscopy analyses of two-
dimensional (2D) crystals (Manchen˜o et al., 2006; Martin-Benito
et al., 2000) have suggested that the pore is formed by three or
four weakly interacting protomers. Each protomer contributes
to the pore with its N-terminal a helix (Hong et al., 2002; Kristan
et al., 2007), and three to four protomers are clearly insufficient to
line a pore with a functional diameter of 2.0 nm (Alvarez et al.,
2009; Kristan et al., 2009). Therefore, the currently accepted
model for actinoporin pores, the toroidal model, assumes that
the pore consists of a toxin tetramer with lipids in the space
between the protomers (Alvarez et al., 2009; Kristan et al.,
2009; Mancheno et al., 2003). The participation of lipids as part
of the pore wall has also been proposed for a-helical peptides
such as melitin, an extract of bee venom (Allende et al., 2005;
Yang et al., 2001), and for colicin E1, another a-PFT (Sobko
et al., 2004). The recently reported structure of a-PFT ClyA
(Mueller et al., 2009) shows 12 protomers assembled into
a cylinder and supports a novel idea: a compact a-helical barrel
architecture motif for a-PFT pores. Moreover, because the
assembly pathway proposed for ClyA is strikingly similar to
that of a-hemolysin, a common mechanism of membrane
permeation that includes a nonpenetrating ring has recently
been proposed for a- and b-PFTs (Bayley, 2009).
Because most a-PFTs do not form well-defined stable oligo-
meric complexes, the mechanisms driving oligomer association
and the transition from the prepore to pore state are still unclear
(Iacovache et al., 2010). These mechanisms are partly under-
stood for b-PFTs, for which it is assumed that more than one
assembly pathway may lead to completion of the ring-like
pore-forming complex (Gonzalez et al., 2008).
To provide further structural information about the oligomeric
nature and pore architecture of PFTs, we determined the
structure of Fragaceatoxin C (FraC), an actinoporin from the
sea anemone Actinia fragacea (Bellomio et al., 2009). Here,
we present the crystal structure of a FraC nonamer and the
cryoelectron microscopy (cryo-EM) reconstruction of a fully
assembled FraC pore inserted in a lipid vesicle. The crystal struc-
ture displays a nonlytic nonamer, or prepore, and provides
mechanistic insights into the molecular determinants governing182 Structure 19, 181–191, February 9, 2011 ª2011 Elsevier Ltd All rpore assembly and detachment of the N terminus for insertion
into the membrane. The cryo-EM reconstruction displays
a FraC functional pore fully compatible with the crystallographic
model. Our results support a pore model in which the
membrane-spanning region is a compact, lipid-free a-helical
bundle.
RESULTS
FraC Crystal Structure
Onemethod for inducing oligomerization of PFTs in solution is to
incubate the toxin with an appropriate detergent (Eifler et al.,
2006). FraC was crystallized in the presence of the detergent
N,N-dimethyldodecylamine N-oxide (LDAO) (Mechaly et al.,
2009). The crystal structure of FraC was solved at 1.8 A˚ resolu-
tion by molecular replacement (MR) and using the atomic
coordinates of Eqt-II (RCSB PDB Code 1IAZ) as search model.
The MR solution contains six copies of the search model per
asymmetric unit (ASU). This solution was used to build the initial
FraC model and then to proceed with the refinement up to reach
the final parameters indicated in Table S1 (available online).
A clear electron density was observed for residues 2 to 178 in
the six copies present in the ASU. The six protomers are ar-
ranged as two groups of three protomers facing each other.
The ASU represents one-third of two concentric and identical
crown-shaped nonamers, and the crystal packing can be
described as alternatively oriented layers of hexagonal arrays
of nonamers in which the central axis is parallel to the crystallo-
graphic z axis (Figures 1A and 1B). The overall external diameter
of each crown is 11.2 nm, and the internal diameter is approxi-
mately 5.2 nm (Figures 1C and 1D). The interface between neigh-
boring protomers involves a small contact area of 600 A˚2
(Figures 1E and 1F) constituting a singular protomer-protomer
assembly (see below). The shape complementarity of protein-
protein interfaces (Lawrence and Colman, 1993) between FraC
protomers is 0.66, a value comparable to those observed in
antibody-antigen complexes (0.66–0.68) and in other oligomeric
interfaces (Garcia et al., 1998). Between two adjacent proto-
mers, there are various hydrogen bonds and hydrophobic
contacts (Table S2).
In total, 54 LDAO detergent molecules (18 per ASU) were
modeled at the interface between two stacking nonamers. These
molecules are located within a region that corresponds to the
basal crown rim (Figures 2A and 2B). Some of the LDAO mole-
cules mediate contacts between protomers of the facing rings
(Figure 2C), and other are contoured by aromatic residues
belonging to a single protomer (Figure 2D). The detergent-rich
interface between two facing rings do not involve direct
protein-protein contacts but detergent-mediated interactions.
Each FraC protomer consists of a b sandwich coremade of ten
b strands and flanked by three helices (Figures 3A and 3B). The
N terminus is attached to the b sandwich and contains a short
b strand (residues 8–10), a one-turn 310 helix (310, residues
11–14), and a short a helix (a1, residues 16–24) (Figure 3B).
The nine N termini line the inner FraC crown wall (Figures 1C
and 1D). The interface between the N terminus and the protein
core corresponds to a buried, solvent-accessible surface of
about 948 A˚2 (Table S3 and Supplemental Experimental Proce-
dures). Through this interface, three types of intramolecularights reserved
Figure 1. FraC Crystal Structure
(A) FraC crystallized in the space group P6322 and six molecules (protomers) make up the crystallographic ASU. Within the ASU the protomers are arranged
as two facing groups, each group consisting of three adjacent protomers (highlighted in red). The ASU constitutes of one-third of two concentric and identical
ring-shaped nonamers.
(B) Applying the crystallographic symmetry, a pattern of stacked layers with opposite orientations along the z axis emerges. These layers alternatively interact
through hydrophilic and detergent-rich regions (shaded in yellow) (see Figure 2).
(C) Top and (D) side views of the FraC nonamer in a ribbon representation, in which the helices are colored red and the b strands blue. The exposed loops and the
molecular surface are shown in gray. In the crown-shaped FraC nonamers, the N-terminal a helices (a1) line the inner wall of the complex and the C-terminal
a helices (a2) form an outer belt.
(E) Neighboring protomers display high shape complementarity, resembling a ‘‘mortise and tenon’’ joint that keeps the protomers together. The relative rotation
between adjacent protomers is 40 (dashed ‘‘V’’).
(F) Val60 (indicated as Val60B) protrudes from one protomer (in blue) and inserts into the hydrophobic cavity lined by residues Phe16, Trp149, and Phe163
(indicated with an ‘‘A’’) of the adjacent protomer (in red).
Structure
X-ray and Cryo-EM Structures of Fragaceatoxin Cinteractions may contribute to maintaining the N terminus in
this conformation: (1) a salt bridge formed between Asp10 and
Lys69 located at the N terminus of the a1 helix, (2) hydrophobic
interactions between the side chains of residues Val8, Leu14,
Leu19, Leu23, and Leu26 and the inner face of the b sandwich
core, and (3) a hydrogen-bond at the C terminus of the a1 helix
between Lys32 and Gly27 (Figure 3C).
The protomer C terminus includes an a helix (a2, residues
130–138) attached to the b sandwich core at the opposite side
to which is located the N terminus (Figure 3B). In the nonamer,
the a2 helices form a belt around the outer face (Figures 1C
and 1D). The a2 helix axis is oriented nearly perpendicular to
the neighboring b strands. Within this helix, residues Tyr133,
Tyr137, and Tyr138 have their aromatic side chain pointing
toward the LDAO molecules (Figure 2D). This region of FraC
contains a chain segment rich in aromatic amino acids that
includes residues Tyr108, Tyr110, Trp112, Tyr113 (Figure 3E).
We will refer to this part of the FraC structure as the basal region.
In the oligomer structure this region constitutes part of the crown
base and most of the aromatic residues within this region have
their side chains in contact with detergent molecules (Figure 2).
Both regions, the a2 helix and the aromatic-rich loop, contain
many highly conserved residues, and in Stn-II form the phospho-Structure 19, 18choline (POC) binding site that appears to participate in
phospholipid recognition (Mancheno et al., 2003) (Figure S1).
In particular, residues Trp112 and Tyr113 seem to play a crucial
role in sphingomyelin (SM) binding (Bakrac et al., 2008). In FraC
structure this binding site encompasses the side chains of
residues Ser54, Val87, Ser105, Pro107, Tyr113, Tyr133,
Tyr137, and Tyr138 (Figure 3E).
The assembly between protomers involves the long loop
between strands b3 and b4 of one monomer (residues 53–68)
(Figure 3A), which is embedded into a grove at the neighboring
protomer formed by the a1 helix and the b sandwich core
(Figures 1E and 1F). At the protomer interface, Val60 protrudes
from one of the protomers and penetrates a cavity that harbors
the Phe16-Trp149-Phe163 aromatic cluster in the next subunit
(Figure 1F). This hydrophobic assembly looks like a ‘‘mortise
and tenon’’ joint that is comprised of two components: the
mortise hole (female) in one protomer and the tenon (male) that
protrudes from the neighboring protomer (Figure 1E).
Comparison with Other Actinoporins
The FraC protomer fold is identical to the fold of the other known
actinoporins solved in a water-soluble state. This was not
unexpected because a high degree of sequence identity and1–191, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 183
Figure 2. Detergent Molecules in FraC Structure
(A) All LDAO detergent molecules (54 in total, 18 per ASU) were modeled at the interface between two stacking nonamers.
(B) An axial view of a ‘‘slice’’ (of about 3.0 nm thick) of the interface between two FraC rings shows that the detergent distribution is along the periphery of the basal
crown rim.
(C) The interactions through the detergent-rich interface do not involve direct protein-protein contacts. This figure shows Trp112 (indicated Trp112A) from the top
protomer and the Trp112 (named Trp112E) from the bottom protomer*, that interact through the stacking arrangement of two detergent molecules LDA203
(LDA203A and LDA203E).
(D) The region inwhich the detergentmolecules are located is rich in aromatic residues. Residues Tyr133, Tyr137, and Tyr138 from the a2 helix orient their aromatic
side chain pointing toward the LDAOmolecules (LDA201-2). Themap in blue around the LDAOmolecules corresponds to a 2Fobs-Fcalc differencemap and level 1
s.
*NOTE: both protomers are crystallographically independents.
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X-ray and Cryo-EM Structures of Fragaceatoxin Csequence similarity occurs between members of the actinoporin
family (Figure S1). A comparison of the FraC protomer with Eqt-II
(Athanasiadis et al., 2001) (RCSB PDB code 1IAZ) and Stn-II
(Mancheno et al., 2003) (RCSBPDBcode1GWY)madeby super-
imposing all of the equivalent Ca atoms resulted in RMSD values
of 0.5 and 0.9 A˚, respectively. The superposition of the three
b sandwich cores (corresponding to amino acids 32–124, and
from 150 to 178 in FraC) showed that the main differences
between Eqt-II and Stn-II monomers and the FraC protomer lie
in the N-terminal region (Figure 3D; see Supplemental Experi-
mental Procedures). This comparison shows that, in FraC, the184 Structure 19, 181–191, February 9, 2011 ª2011 Elsevier Ltd All rN-terminal domain is more ‘‘released’’ from the protein core
than in the other two structures. In fact, when the threemolecules
were analyzed inmoredetail, weobserved that the increase in the
solvation free energy (DG) between the N termini and their corre-
sponding cores was lower in FraC than in the other two mono-
meric actinoporin structures (Table S3). These calculations indi-
cated that, if accounting only for the contribution of the
solvation energy, the FraC N terminus can detach from the core
at a cost about 12% lower than that in Eqt-II or Stn-II.
We observed that Phe16 is located at one end of the a1 helix
of FraC (Figure 3C) and also in Eqt-II (Figure 4A). In monomericights reserved
Figure 3. FraC Protomer Structure
(A) The FraC protomer topology is composed of
ten b- strands and three short helices (310, a1,
and a2).
(B) Ribbon representations of a FraC protomer.
The structure consists of a b sandwich core
flanked at one side by the b1-strand, and the 310
and a1 helices, all located at the N terminus, and
at the opposite side by the N-terminal a2 helix.
(C) The residues that maintain the amphipathic N
terminus attached to the b sandwich core are
shown as sticks. The interaction established
include: a salt bridge between Asp10 and Lys69
(dashed yellow line); hydrophobic interactions
between the core and residues Leu14, Leu19,
Leu23, and Leu26; and a hydrogen bond between
Lys32 and Gly27 (dashed black line).
(D) Superposition of the core a-carbons of the
three actinoporin crystal structures: FraC proto-
mer in blue, Eqt-II (RCSB PDB Code 1IAZ) in red,
and Stn-II (RCSB PDB Code 1GWY) in gray. Only
the a-carbons are shown. The RMSD between a-
carbons of FraC and Eqt-II is 0.5 A˚, and between
FraC and Stn-II is 0.9 A˚.
(E) The POC binding site described for Stn-II (Man-
cheno et al., 2003) is located close to a region rich
in aromatic residues. In the case of FraC the POC
binding site involve residues Ser54, Val87, Ser105,
Pro107, Tyr113, Tyr133, Tyr137, and Tyr138. See
also Figure S1.
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X-ray and Cryo-EM Structures of Fragaceatoxin CEqt-II, the benzyl side chain of Phe16 is pointing to the monomer
core, and forming an aromatic cluster with Trp149 and Phe163
(Figure 4A). In oligomeric FraC, however, Ile59 and Val60 (labeled
Ile59B and Val60B in Figures 4B,monomer in pink) from the adja-
cent protomer disrupt these aromatic interactions between
Phe16, and the side chains of Trp149 and Phe163 (labeled
Phe16A and Trp149A and Phe163A in Figure 4B, monomer in
blue).
The short 310 helix observed at the N terminus of the FraC pro-
tomer (Figures 3B, 3C, and 4B) is also present in the structures of
Eqt-II (RCSB PDB Code 1IAZ) (Figure 4A) and Stn-II (Mancheno
et al., 2003) (RCSB PDB code 1GWY). Nevertheless, the authors
that solved the structures of these actinoporins did not reportStructure 19, 181–191, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 185t
,this secondary element. This type of
helix is also found in the monomeric
ClyA (Mueller et al., 2009) (see below).
Cryo-EM Reconstruction
of a Functional Pore
An alternative way to induce oligomeriza-
tion of PFTs in vitro is to incubate the
toxin with lipid vesicles (Tilley et al.,
2005). Accordingly, to investigate the
structure of functional pores, we carried
out cryo-EM studies of FraC in the pres-
ence of large, unilamellar vesicles (LUV)
composed of an equimolar mixture of
dioleoyl-phosphatidylcholine (DOPC) and
SM. LUVs of this composition were
rapidly permeabilized by FraC, and theirencapsulated contents were released (Figure S2), indicating
the formation of functional pores.
After incubation with FraC, most of the liposomes appeared to
be heavily decorated with pores (Figure 5A).
In the cryo-EM micrographs, inserted pores with differen
orientations could be observed. While in the top (T) and tilted
(t) views, the FraC oligomers were observed as small circles
in the side views (S), they appeared as particles with 2-fold
symmetry, corresponding to pores lining the edges of the
LUVs (top left panel in Figure 5A). A 2D and reference-free image
classification of 3,652 manually selected images was used to
generate a 3D density map by a common-lines procedure and
iterative refinement (see Experimental Procedures). The resulting
Figure 4. Phe16 Side-Chain Rearrangement upon FraC Oligomerization
(A) In the crystal structure of the monomeric Eqt-II (RCSB PDB Code 1IAZ) the benzyl side chain of Phe16 is fully extended, forming an aromatic cluster with
Trp149 and Phe163. The 310 helix at the N-terminal found in FraC is also present in Eqt-II.
(B) In the oligomeric FraC structure, Val60 (indicated as Val60B) from the tenon protomer (model in pink) extends the side chain and interacts with amino acids
Trp149 and Phe163 (labeled, respectively, Trp149A and Phe163A) of themortise protomer (model in blue). Conversely, Phe16 from onemortise protomer strongly
interacts with Ile59 at the tenon protomer (see Figure 1F and Table S2B).
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X-ray and Cryo-EM Structures of Fragaceatoxin Cmap is rendered in Figures 5B (outer surface) and Figure 5C
(inner surface). It depicts a landscape in which a well-defined
central oligomer (labeled ‘‘i’’) is surrounded by less defined olig-
omers (labeled ‘‘ii’’), reflecting the close packing of FraC in these
vesicles. A large, extramembrane region lies at the outer surface
of the vesicles (Figure 5B), delimiting a conical pore that
traverses the membrane, with the narrow opening toward the
interior of the vesicle (Figure 5C).
The moderate resolution of the EM map does not allow
resolving individual subunits, and the oligomeric state of FraC
in the lipid vesicles cannot be observed directly. However,
comparisons between the dimensions of the EM map and
several possible n-fold oligomers reveal that the overall pore
architecture of the cryo-EM reconstruction corresponds nicely
with the nonameric structure obtained by X-ray crystallography
(Figure S3). Accordingly, we performed a new refinement of
the 3D map where 9-fold symmetry was imposed (Figure 5D),
yielding improved resolution (30 A˚) (Figure S5) and better
defined structural features. In this improved reconstruction
a unique central pore emerged to accommodate the crystallo-
graphic model of FraC, but the surrounding elements were
diffuse due to the averaging imposed by the 9-fold symmetry.
The cut-away view in Figure 5E reveals a tapered central pore
that resembles a funnel. Its wider internal radius at the top is
approximately 5.0 nm, which is similar to that of the crystallo-
graphic FraC oligomer (Figure 1C). However, the narrow opening
at the bottom is about 1.5 nm in diameter, suggesting that upon
membrane binding FraC experiments important conformational
changes.
Based on the crystallographic structure and the 9-fold
symmetrized cryo-EM map, we built a putative model for a
FraC protomer in the membrane-inserted conformation (Fig-
ure 6A; see Supplemental Experimental Procedures) and in the
corresponding nonameric form (Figure 6B). The model has an
extracellular domain made of nine FraC cores, as modeled in
the crystal structure, and an a helix tapered bundle spanning186 Structure 19, 181–191, February 9, 2011 ª2011 Elsevier Ltd All rthe membrane (Figure 5E). The correlation between the cryo-
EM map and the nonameric pore improves from 0.78 to 0.8
when inserted a helices are considered (Figures 5D and 5E).
Our model has architecture very similar to the transmembrane
region observed in the octameric Wza protein, a translocon for
E. coli capsular polysaccharides (Dong et al., 2006) (Figure 6B,
inset). The model for the FraC pore consists of nine contacting
helices that contour a pore of 1.5 nm in diameter (Figure 6B).
DISCUSSION
Membrane Binding, Protomer Circularization,
and Prepore
The bottom rim of the FraC nonameric structure includes the
promoter’s basal region which is rich in aromatic residues (Fig-
ure 3E). Because tyrosines and tryptophans tend to concentrate
at the membrane-water interface (Killian and von Heijne, 2000),
we suggest that FraC a2 helices would lie on the plane of the
membrane in the membrane-bound state. These helices would
provide anchoring sites to the protomer upon membrane inser-
tion and would contribute to the stability of the b sandwich,
which is necessary to build the pore (Kristan et al., 2004).
Oligomerization requires two steps: binding the monomers to
the target membrane in the appropriate orientation (‘‘up and
down’’ or ‘‘vertical’’ orientation), and bringing the monomers
(protomers) into contact through the oligomerization interface
(‘lateral’ orientation). In the case of Eqt-II, an exposed
aromatic-rich loop (residues 106–116) has been shown to partic-
ipate in initial binding to the target membrane (Hong et al., 2002;
Kristan et al., 2004). Consequently, this exposed aromatic-rich
loop facilitates oligomerization by helping to discriminate
between up and down (Hong et al., 2002; Malovrh et al., 2003).
Lateral orientation is achieved by the POC binding site and its
specific affinity for the interfaces of coexisting lipid phases (Ale-
gre-Cebollada et al., 2006; Barlic et al., 2004). Thus, toxin mono-
mers might form a one-dimensional array along the lipidights reserved
Figure 5. Cryo-EM of FraC Pores in Lipid Vesicles
(A) Field of a cryo-EM micrograph showing FraC pores inserted in LUVs. Representative views are enclosed within circles (top and tilted views) or squares (side
views). The inset shows some of the averages obtained after 2D classification. These averages are attributed to top (T), side (S), or tilted (t) views of the oligomeric
pores. Rendering the cryo-EMmap for FraC pores without imposed symmetry shown as seen from the outer (B) or inner (C) surface of the vesicles. The top (D) and
cut-away side (E) semitransparent renderings of the 9-fold symmetry 3Dmap allow for visualization of the fitted atomic model for FraCwith the N-terminal amphi-
pathic a helices inserted into the membrane. The dashed gray lines in (E) delineate the approximate width of the lipid bilayer. The thumbnails in (D) and (E) indicate
the orientations of the panels. See also Figures S2–S5.
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X-ray and Cryo-EM Structures of Fragaceatoxin Cinterfaces with their a2 helices facing the SM-rich phase. This
orientation leaves the protein face containing the mortise and
that containing the tenon pointing toward opposite directions
along the lipid interface. Most likely, these events help oligomer-
ization because they brings into contact the complementary
sides of the protomers that eventually form the pore. Accumula-
tion of the toxin along this one-dimensional space not only acts
as an efficient concentration strategy but also releases the linear
tension that keeps the lipid phases apart and results in lipid mix-
ing (Garcia-Saez et al., 2007). In randombinding, the assembly of
functional nonamers within the plane of the membrane would be
a very unlikely event, and high concentrations of the toxin would
be needed to observe lytic effects. In contrast, actinoporins
exhibit their lytic effects even at subnanomolar concentrations
(Macek and Lebez, 1988). However, although hemolysis occurs
quickly, it does not take place immediately after the addition of
the toxin to an erythrocyte suspension. Instead, a concentra-
tion-dependent lag precedes hemolysis (Macek and Lebez,
1981), which probably corresponds to the time needed for the
toxin monomers to reach the cell and oligomerize to make a pre-
pore, the structure preceding the functional pore. This delay has
been observed for Eqt-II in giant unilamellar vesicles (GUV), inStructure 19, 18which, after a lag time of approximately 20 min, the vesicles
are permeabilized within 1 to 5 min (Schon et al., 2008).
As mentioned before, in the FraC oligomer, a1 helices face the
internal crown surface and attach to the main b sandwiches.
Because the N termini must be inserted into the membrane for
functional pore formation, the crystal structure of FraC repre-
sents a nonlytic conformation. This oligomeric structure is fully
compatible with our cryo-EM reconstruction of functional pores.
Therefore, the crystallographic FraC oligomer (Figures 1C and
1D) can be assumed to be a high-resolution model of an actino-
porin in its prepore state.Prepore to Pore Transition
Once an actinoporin is attached to the target cell, the N-terminal
a helix must reorient and penetrate the membrane to make
a membrane pore (Gutierrez-Aguirre et al., 2004; Hong et al.,
2002; Malovrh et al., 2003). This change in conformation at the
N terminus appears to be coupled to oligomerization (Macek
et al., 1995), but the molecular events triggering release of the
a1 helix from the protein core are not completely understood.
The FraC crystal structure allows us to better understand how1–191, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 187
Figure 6. FraC Pore Model
(A) The X-ray crystallographic FraC protomer structure
was used to build a model in the membrane inserted
conformation (see Supplemental Experimental Proce-
dures). The N-terminal undergoes the major rearrange-
ment including detachment from the protein core, a rota-
tion of about 180, and the extension of its helical
segment (compare this model with Figure 3B). Amino
acids 2–27 were rotated as a rigid body around Gly27,
and the two nonhelical portions (residues 2–15 and 25–
27, shown in green) were forced to adopt a continuous
a helix structure.
(B) The application of 9-fold symmetry to the protomer
structure yields a putative model of the functional pore.
Inset: a-helical bundle corresponding to the transmem-
brane region of Wza, a translocon for E. coli capsular poly-
saccharides (Dong et al., 2006) (RCSB PDB Code 2J58).
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X-ray and Cryo-EM Structures of Fragaceatoxin Cthe oligomerization process can drive the necessary structural
changes that promote membrane permeation.
It has already been established that membrane insertion may
proceed through the M2 intermediary (Alegre-Cebollada et al.,
2007), in which the a1 helix detaches from the main body of
the molecule and resides transiently at the membrane-water
interface (Hong et al., 2002; Malovrh et al., 2003). The a1 helix
in FraC runs from Phe16 to Glu24, in Eqt-II, it includes residues
Phe16 to Leu26, and in Stn-II, this helix consists of Thr13 to
Glu23. However, when inserted into the membrane, the N-
terminal a helix of Eqt-II extends from Asp10 to Asp28 (Malovrh
et al., 2003). This elongation is necessary to cross the lipid
bilayer, which spans a distance of about 3–4 nm. Regarding
the limited space in the FraC structure, the a1 helixmust elongate
after the N terminus has changed its orientation, contacting the
lipids in the central lumen.
One interesting feature of actinoporins is the presence of
a one-turn 310 helix located at the N terminus between the b2
strands and the a1 helix. The a helix is the predominant type of
helix found in protein structure, with an occurrence of about
80%. Only 20% of these helices correspond to 310 helices
(Barlow and Thornton, 1988). Interestingly, 310 helices have
been proposed to be intermediates in the folding/unfolding of
a helices (Millhauser, 1995). Moreover, molecular dynamic
simulations in polypeptides have indicated that the propensity
of a-helical conformations increases with the hydrophobicity of
the medium, whereas for 310 helices, the propensity decreases
(Sorin et al., 2006). This characteristic of 310 helices is consistent
with the fact that the N-terminal segment in actinoporins
converts into a long a helix upon membrane insertion.
The conversion of a 310 helix into an a helix following
membrane binding has been observed in ClyA. The ClyA mono-
mer consists of a long four helix bundle with a subdomain named
the b-tongue, and this subdomain contains two short 310 helices,
one at the N terminus of helix D and a second in the loop con-
necting strands b1 and b2 (Wallace et al., 2000). This region
undergoes a structural rearrangement to change into a long
a helix in the membrane-bound state (Mueller et al., 2009). Anal-
ogous to what has been observed in ClyA, we propose that, in
actinoporins, the transition from the nonlytic conformation to
a functional pore includes a hypothetical intermediate state
that resembles the conformational switch observed in the exten-
sion of helices in ClyA (Mueller et al., 2009).188 Structure 19, 181–191, February 9, 2011 ª2011 Elsevier Ltd All rUpon membrane insertion, the N-terminal segment is trans-
ferred across the bilayer (Kristan et al., 2007). In FraC, this
transition is most likely mediated by Gly27, which is located in
a loop at the base of the protomer and is hydrogen-bonded to
Lys32. This residue might function as a hinge that facilitates
this significant conformational change. In fact, in Eqt-II,
a Gly27Cys mutation decreases its hemolytic activity to 17%
of that of wild-type (Malovrh et al., 2003). A fact that supports
that Gly27 and Lys32 play an important role is that these two
residues are conserved in all actinoporins described so far
(Figure S1).
We propose that, upon oligomerization, Val60 from one proto-
mer (tenon) displaces Phe16 from the adjacent protomer
(mortise), disrupting the interactions within the aromatic cluster
Phe16-Phe163-Trp149. The side chain of Phe16 (Phe16A, in
Figure 4B) changes its orientation that was occupying in the
monomeric state (most likely identical to Phe16 of Eqt-II, as is
shown in Figure 4A), and, in this new conformation, interacts
with the Ile59 from the neighboring protomer (Ile59B in Fig-
ure 4B). This switching of the Phe16 interaction may cause the
release of the N-terminal from the b sandwich, allowing it to
detach from the core and reach the membrane surface. Once
in contact with the lipids, the hydrophobic environment triggers
elongation of the a helix and insertion into themembrane. Hence,
in our mechanistic view, prepore formation is a crucial step
because it may also allow membrane insertion. However, oligo-
merization is necessary, but not sufficient, to induce the
N-terminal conformational change. The presence of a bilayer
with an appropriate lipid composition is also required for PFTs
to permeate membranes.
Hypothetical a-Helical Bundle Pore Model
In solution, FraC permeabilizes LUVs made of a model lipid
composition DOPC:SM (1:1) (Bellomio et al., 2009). Cryo-EM
images of these model membranes incubated with FraC show
that the toxin makes ring-like structures that cover the entire
membrane surface. The 3D reconstruction of the ring-like motif
reveals a conical shape that traverses the membrane with the
smaller aperture toward the inner space of the vesicle. Improving
the reconstruction by averaging with 9-fold symmetry, we find
a map shaping a funnel with large and small apertures of about
5.0 and 1.5 nm, respectively (Figures 5D and 5E). As the esti-
mated functional pore diameter of other actinoporins is aboutights reserved
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X-ray and Cryo-EM Structures of Fragaceatoxin C2 nm (Alvarez et al., 2009; Belmonte et al., 1993; de los Rios et al.,
1998; Tejuca et al., 2001), our cryo-EM reconstruction of the
FraC pore is in full agreement with former biochemical studies.
In turn, the cryo-EM reconstruction of functional FraC pores
supports the physiological relevance of the nonameric crystal-
lographic model. Consequently, we constructed a pore model
in which the nine N termini assemble as a compact a-helical
bundle. In contrast to proposals for the toroidal model (Al-
varez et al., 2009; Kristan et al., 2009; Mancheno et al.,
2003), in our actinoporin pore model, lipids are not part of
the pore wall.
In conclusion, the work presented here includes a high-resolu-
tion crystal structure and cryo-EM reconstructions of FraC in-
serted into a membrane, shedding light on the architecture and
sequential events that lead to pore formation by actinoporins.
Furthermore, our FraC pore model agrees with a concept that
emerged from examining the structure oligomeric ClyA:
amembrane pore can be constructed exclusively with protein ar-
ranged in an a-helical bundle.
EXPERIMENTAL PROCEDURES
FraC Purification, Crystallization, and Structure Resolution
Full details of FraC purification (Bellomio et al., 2009), crystallization and data
collection have been recently published (Mechaly et al., 2009). FraC structure
was solved by molecular replacement (MR) with the program Phaser (McCoy,
2007) and using as searching model one monomer of Eqt-II structure (Athana-
siadis et al., 2001; RCSB PDB Code: 1IAZ). The MR solution was found in
space group P6322 and contained six molecules per asymmetric unit. After
the first round of structure and anisotropic B factor refinement with the
program phenix.refine (Adams et al., 2004), many clear elongated regions of
positive electron density were observed. These regions were located close
to the aromatic rings of Trp112 and into a site corresponding to the POC
binding site described in Stn-II (Mancheno et al., 2003). At this stage the MR
solution was modified with the program Coot (Emsley and Cowtan, 2004) to
change the amino acids to those corresponding to the FraC sequence. Further
refinement rounds included noncrystallographic symmetry (NCS) restrictions
and model rebuilding by addition of both water and LDAO molecules. The
LDAO detergent molecules were traced within the elongated regions of the
2Fobs- Fcalc and Fobs-Fcalc maps. Within the asymmetric unit, a total of 938
water and 18 LDAO molecules were modeled (Table S1). The final FraC model
has a good quality as estimated by the programMolProbity (Davis et al., 2007)
and corresponds to a 1.8 A˚ resolution structure. The overall Rcryst and Rfree
values are 19% and 23%, respectively (Table S1).
Lipid Vesicles Preparation
The encapsulation of ANTS and DPX in LUVs of DOPC-SM (1:1) and FraC-
mediated permeabilization of the vesicles were carried out as previously
described (Bellomio et al., 2009). LUVs of the same lipid composition used
for cryo-EM were prepared by extrusion (Mayer et al., 1986). The lipids dis-
solved in chloroform:methanol (2:1) were dried with N2 in a glass tube and
then placed 2 hr in vacuum to remove traces of chloroform. They were then re-
suspended in 10mMHEPES, 50mMNaCl (pH 7.5) and subjected to ten cycles
of freezing and thawing in liquid nitrogen and a 45C water bath. The lipid
suspension was extruded 10 times through polycarbonate filters with a pore
diameter of 0.1 mm (Nucleopore, Pleasanton, CA) to obtain LUVs 1 mM lipids
final concentration.
Cryo-EM of FraC Inserted in Model Membranes
For cryo-EM studies, LUVs were incubated with FraC (1 mg/ml) for 30 min.
Cryo-EM grids were prepared following standard procedures and observed
at liquid nitrogen temperature in a JEM-2200FS/CR transmission electron
microscope (JEOL Europe, Croissy-sur-Seine, France) operated at 200 kV.
An in-column omega energy filter helped to record images with improved
signal to noise ratio by zero-loss filtering. Digital images were recorded onStructure 19, 18CCD camera under low-dose conditions, at a magnification of 86,862 obtain-
ing a final pixel size of 1.72 A˚/pixel. Manual selection provided a set of 3652
individual particles for pores in LUV of DOPC-SM.
The images were CTF-corrected by flipping phases after estimation of CTF
parameters in EMAN (Ludtke et al., 1999). The 2D images were classified by
maximum-likelihood-based procedures within the XMIPP (Scheres et al.,
2008). The starting 3D model was generated using reference-free alignment,
classification and common-lines procedures implemented in EMAN. This
was followed by iterative refinement using a projection matching scheme in
SPIDER package (Baxter et al., 2007).
The rigid body fitting was performed semiautomatically by maximization of
the sum of map values at atom positions, and by improvement in the coeffi-
cient of correlation between simulated maps from the atomic structures and
the cryo-EM density map in Chimera (Pettersen et al., 2004). This software
was also used to create the figures. The cryo-EM maps were calculated with
no symmetry or imposing 9-fold symmetry. The total set of images was split
into two halves, two density maps were calculated and the resolution was esti-
mated by Fourier Shell Correlation at 0.5 and 0.15 thresholds between these
two maps. Additionally, correlations between the atomic structure of FraC
and the 9-fold symmetrized cryo-EM map suggest a resolution around 30 A˚
(Figure S5).
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